Alnylam Pharmaceuticals, Inc. (ALNY)
295.91
-13.58
(-4.39%)
USD |
NASDAQ |
May 01, 16:00
296.18
+0.27
(+0.09%)
After-Hours: 20:00
Alnylam Pharmaceuticals Shareholders Equity (Quarterly) : 789.18M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 86.48B |
| Gilead Sciences, Inc. | 22.70B |
| Ionis Pharmaceuticals, Inc. | 491.41M |
| Eli Lilly & Co. | -- |
| Sarepta Therapeutics, Inc. | 1.141B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.026B |
| Total Liabilities (Quarterly) | 4.236B |
| Debt to Equity Ratio | 3.762 |
| Current Ratio | 2.762 |
| Net Debt Paydown Yield | -0.09% |